Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Exagen (XGN) Assets (2018 - 2025)

Historic Assets for Exagen (XGN) over the last 8 years, with Q3 2025 value amounting to $62.8 million.

  • Exagen's Assets rose 4407.29% to $62.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $62.8 million, marking a year-over-year increase of 4407.29%. This contributed to the annual value of $44.7 million for FY2024, which is 2152.11% down from last year.
  • Per Exagen's latest filing, its Assets stood at $62.8 million for Q3 2025, which was up 4407.29% from $58.8 million recorded in Q2 2025.
  • Exagen's 5-year Assets high stood at $137.5 million for Q1 2021, and its period low was $40.3 million during Q1 2025.
  • Moreover, its 5-year median value for Assets was $64.2 million (2023), whereas its average is $81.6 million.
  • Its Assets has fluctuated over the past 5 years, first soared by 6559.19% in 2021, then tumbled by 4002.97% in 2023.
  • Quarter analysis of 5 years shows Exagen's Assets stood at $123.4 million in 2021, then plummeted by 30.15% to $86.2 million in 2022, then tumbled by 33.96% to $56.9 million in 2023, then fell by 21.52% to $44.7 million in 2024, then skyrocketed by 40.58% to $62.8 million in 2025.
  • Its last three reported values are $62.8 million in Q3 2025, $58.8 million for Q2 2025, and $40.3 million during Q1 2025.